Oncology

Chronic Lymphocytic Leukemia

Advertisement

Conference Reporter in Chronic Lymphocytic Leukemia to Cover Key Topics Being Presented at the 63rd ASH Annual Meeting and Exposition

conference reporter by Anthony R. Mato, MD, MSCE; Jan A. Burger, MD, PhD; Matthew S. Davids, MD, MMSc

Overview

Conference Reporter delivers health care providers with insights from key thought leaders on exciting news presented at major medical conferences, in a concise and timely format. This issue of Conference Reporter will feature coverage of selected topics in Chronic Lymphocytic Leukemia presented at this year’s ASH Annual Meeting.

The clinicians who were surveyed selected the following expert commentators and topics from the upcoming conference.

Community-Selected Expert Commentators:

Jan A. Burger, MD, PhD 

Professor, Tenured, Department of Leukemia Division of Cancer Medicine The University of Texas MD Anderson Cancer Center Houston, TX

Matthew S. Davids, MD, MMSc 

Associate Professor of Medicine Harvard Medical School Director of Clinical Research, Division of Lymphoma Dana-Farber Cancer Institute Boston, MA

Anthony R. Mato, MD, MSCE 

Director, Chronic Lymphocytic Leukemia Program Associate Attending, Memorial Sloan Kettering Cancer Center New York, NY

Community-Selected Topics: 

    Extending Progression-Free and Overall Survival in Chronic Lymphocytic Leukemia •    Taking a “Whole Patient” Approach to Treating Chronic Lymphocytic Leukemia •    Data on Investigational Novel-Novel Combinations for Chronic Lymphocytic Leukemia •    Long-term Survival Data With Preferred Frontline Therapies for Chronic Lymphocytic Leukemia •    Chronic Lymphocytic Leukemia: Real-World Data on Testing and Treatment •    Chronic Lymphocytic Leukemia Treatment Patterns in the Era of Novel Agents

This information is brought to you by Engage Health Media and is not sponsored, endorsed, or accredited by the American Society of Hematology.

Anthony R. Mato, MD, MSCE

Director, Chronic Lymphocytic Leukemia Program
Associate Attending, Memorial Sloan Kettering Cancer Center
New York, NY

Jan A. Burger, MD, PhD

Professor, Tenured, Department of Leukemia
Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center
Houston, TX

Matthew S. Davids, MD, MMSc

Associate Professor of Medicine
Harvard Medical School
Director of Clinical Research, Division of Lymphoma
Dana-Farber Cancer Institute
Boston, MA

Advertisement